Provided by Tiger Trade Technology Pte. Ltd.

CMS Energy Corp

68.27
-1.5600-2.23%
Post-market: 69.120.8539+1.25%19:58 EDT
Volume:3.73M
Turnover:255.81M
Market Cap:21.41B
PE:20.50
High:70.09
Open:70.09
Low:68.25
Close:69.83
52wk High:80.36
52wk Low:68.25
Shares:313.58M
Float Shares:311.85M
Volume Ratio:1.04
T/O Rate:1.19%
Dividend:2.23
Dividend Rate:3.26%
EPS(TTM):3.33
EPS(LYR):3.52
ROE:9.16%
ROA:2.97%
PB:2.24
PE(LYR):19.37

Loading ...

CMS Energy Declares Quarterly Dividend of 57 Cents a Share

Reuters
·
Jul 21

CMS Energy Corp - Declares Qtrly Dividend of $0.57 Per Share

THOMSON REUTERS
·
Jul 21

CMS Energy's Board of Directors Declares Quarterly Dividend on Common Stock

THOMSON REUTERS
·
Jul 21

Jefferies Adjusts Price Target on CMS Energy to $78 From $74, Maintains Hold Rating

MT Newswires Live
·
Jul 16

CMS Receives Clinical Trial Approval for Its Novel Complement Factor B Inhibitor in Age-Related Macular Degeneration

Stock News
·
Jul 15

Barclays Adjusts CMS Energy Price Target to $81 From $79, Maintains Overweight Rating

MT Newswires Live
·
Jul 14

CMS Energy is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

CMS Energy Corporation : Barclays Raises Target Price to $81 from $79

THOMSON REUTERS
·
Jul 14

Aroa Biosurgery Says Randomized Controlled Trial for Symphony Product Meets Primary Endpoint

MT Newswires Live
·
Jul 14

Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates

TIPRANKS
·
Jul 14

Arhaus Names Meijer CEO Rick Keyes to Board as Independent Director

Reuters
·
Jul 14

InSilico Medicine, CMS Expand Drug Development Partnership

MT Newswires Live
·
Jul 13

Truist Securities Adjusts CMS Energy Price Target to $85 From $83

MT Newswires Live
·
Jul 10

CMS Energy's Q2 Earnings Likely Weighed Down by Unfavorable Weather, UBS Securities Says

MT Newswires Live
·
Jul 09

Consumers Energy Tops Michigan Land Restoration Goal Early, Reaches 6,700 Acres

Reuters
·
Jul 09

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

GlobeNewswire
·
Jul 08

4 ETF Winners of June Likely to Gain in July

zacks
·
Jul 08

Nyxoah Rides U.S. Momentum and CMS Boost in Strong Q2 Preliminary Results

TIPRANKS
·
Jul 08

Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus

Simply Wall St.
·
Jul 08

CMS Energy to Report Q2 2026 Results, Issue Outlook in Webcast

Reuters
·
Jul 08